Saul Priceman Lab Team Group Lab Members standing together

Saul Priceman Lab

Our lab’s primary focus is targeting prostate, breast, ovarian and pancreatic cancers. Our preclinical studies are aimed at understanding the tumor microenvironment, limitations to solid tumor immunotherapies, and developing novel therapies for clinical translation. To date, we’ve initiated three phase 1 trials at City of Hope assessing chimeric antigen receptor (CAR) T cell therapy for the treatment of patients with bone metastatic prostate cancer, breast cancer brain metastasis, and advanced ovarian cancer.